Key Points
- A high glutamine ratio was directly correlated to tumor aggression and metastatic capability. Patients with this profile had the worst prognosis for survival.
- The study uncovered a direct relationship between glutamine and STAT3, a key biomarker for ovarian cancer.
- Ovarian cancer may be susceptible to multidrug cocktails tailored to match the metabolic profile of a patient’s tumor.
Celý článek: The ASCO Point
